Technologies related to Hyperlipidemia

Gene Therapy for Niemann-Pick Disease Type C
Ref: E-185-2014/0 | Updated: Apr 18, 2016
Cannabinoid Receptor Meditating Compounds for Metabolic Disease
Ref: E-140-2014/0 | Updated: Aug 23, 2017
Treatment of Chronic Kidney Disease with Synthetic Amphipathic Peptides
Ref: E-743-2013/0 | Updated: Jun 2, 2014
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Ref: E-342-2013/0 | Updated: Mar 18, 2014
Methods of Retaining Methylation Pattern Information in Globally Amplified DNA
Ref: E-243-2013/0 | Updated: Feb 6, 2014
Automated Microscopic Image Acquisition, Compositing and Display Software Developed for Applied Microscopy/Cytology Training and Analysis
Ref: E-228-2013/0 | Updated: Feb 6, 2014
Therapeutic, Bifunctional Janus Microparticles with Spatially Segregated Surface Proteins and Methods of Production
Ref: E-457-2013/1 | Updated: Jan 28, 2014
Photoinduced Electron Transfer Fluorescent Primer for Nucleic Acid Amplification
Ref: E-292-2013/0 | Updated: Feb 17, 2016
Fluorescent Primer(s) Creation for Nucleic Acid Detection and Amplification
Ref: E-252-2013/0 | Updated: Jan 27, 2014
Use of Detector Response Curves to Optimize Settings for Mass Spectrometry
Ref: E-157-2013/0 | Updated: Jan 20, 2014
Therapeutic Peptide Treatment for Dyslipidemic and Vascular Disorders
Ref: E-138-2008/0 | Updated: Aug 8, 2016
Coacervate Microparticles Useful for the Sustained Release Administration of Therapeutic Agents
Ref: E-116-2004/0 | Updated: Jun 29, 2017
ApoA-1 Mimetic Peptides Promoting Lipid Efflux from Cells for Treatment of Vascular Disorders
Ref: E-114-2004/0 | Updated: Nov 29, 2016
Knockout Mouse Models for Study of Cholesterol Biosynthesis and Metabolic Diseases
Ref: E-323-2001/0 | Updated: Jan 20, 2016
Subscribe to Technologies related to Hyperlipidemia